Madrigal Pharmaceuticals
MDGL
MDGL
385 hedge funds and large institutions have $13.7B invested in Madrigal Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 137 increasing their positions, 113 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
9% more funds holding
Funds holding: 352 → 385 (+33)
1.57% less ownership
Funds ownership: 105.34% → 103.77% (-1.6%)
7% less funds holding in top 10
Funds holding in top 10: 14 → 13 (-1)
Holders
385
Holding in Top 10
13
Calls
$323M
Puts
$271M
Top Buyers
| 1 | +$87.7M | |
| 2 | +$79M | |
| 3 | +$74.4M | |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$72.9M |
| 5 |
Alkeon Capital Management
New York
|
+$61.3M |
Top Sellers
| 1 | -$132M | |
| 2 | -$102M | |
| 3 | -$58.6M | |
| 4 |
Morgan Stanley
New York
|
-$50.7M |
| 5 |
AAA
Affinity Asset Advisors
New York
|
-$42.8M |
